Elucidation of the microRNA-mediated RNA networks in castration resistant prostate cancer and development of innovative treatments
Project/Area Number |
16H05462
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Chiba University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
関 直彦 千葉大学, 大学院医学研究院, 准教授 (50345013)
坂本 信一 千葉大学, 医学部附属病院, 講師 (70422235)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥17,030,000 (Direct Cost: ¥13,100,000、Indirect Cost: ¥3,930,000)
Fiscal Year 2018: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2016: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
|
Keywords | 前立腺癌 / 癌抑制 / 転移抑制 / 去勢抵抗性 / マイクロRNA / 泌尿器癌 / microRNA / マイクロRNA / microRNA |
Outline of Final Research Achievements |
We constructed the microRNA (miRNA) expression signature of castration-resistant prostate cancer (CRPC) using clinical specimens, and investigated the functional significance of tumor-suppressive miRNAs. We further investigated oncogenes regulated by the tumor-suppressive miRNAs. We have revealed that miR-452, miR-320a, miR-26a/b, miR-29a/b/c, miR-218, miR-145-3p, miR-150-5p/3p, miR-205-5p, miR-99a-3p, miR-455-5p/3p, and miR-199a/b-3p function as tumor suppressors in prostate cancer. We have also identified the genes regulated by those miRNAs.
|
Academic Significance and Societal Importance of the Research Achievements |
前立腺癌で発現異常を認めるマイクロRNAの機能性RNA分子ネットワークの解析を行うことにより、前立腺癌やCRPCの機能性RNA分子ネットワークの解析を進める事ができた。それらが制御する癌遺伝子は前立腺癌の予後を予測することが可能な分子マーカーであった。これにより、前立腺癌の診療、特に去勢抵抗性前立腺癌の診断や治療への道筋をつけることができた。今後の研究の展開により新規治療法を確立するための基盤を整えることができた。
|
Report
(4 results)
Research Products
(29 results)
-
-
-
[Journal Article] Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC2018
Author(s)
Arai, T. Okato, A. Yamada, Y. Sugawara, S. Kurozumi, A. Kojima, S. Yamazaki, K. Naya, Y. Ichikawa, T. Seki, N.
-
Journal Title
Cancer Med
Volume: 7(5)
Issue: 5
Pages: 1988-2002
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma2018
Author(s)
Yamada, Y. Arai, T. Kojima, S. Sugawara, S. Kato, M. Okato, A. Yamazaki, K. Naya, Y. Ichikawa, T. Seki, N.
-
Journal Title
Oncotarget
Volume: 9 (42)
Issue: 42
Pages: 26638-58
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance2018
Author(s)
Yamada, Y. Arai, T. Kojima, S. Sugawara, S. Kato, M. Okato, A. Yamazaki, K. Naya, Y. Ichikawa, T. Seki, N.
-
Journal Title
Cancer Sci
Volume: 109 (9)
Issue: 9
Pages: 2919-2936
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation2018
Author(s)
Yamada, Y. Sugawara, S. Arai, T. Kojima, S. Kato, M. Okato, A. Yamazaki, K. Naya, Y. Ichikawa, T. Seki, N.
-
Journal Title
Int J Urol
Volume: 25(11)
Issue: 11
Pages: 953-965
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy.2018
Author(s)
Takei A, Sakamoto S, Wakai K, Tamura T, Imamura Y, Xu M, Maimaiti M, Kawamura K, Imamoto T, Komiya A, Akakura K, Ichikawa T.
-
Journal Title
Int J Urol.
Volume: 25
Issue: 4
Pages: 352-358
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Biparametric Prostate Imaging, the Reporting and Data System, Version 2, and International Society of Urological Pathology Grade Predict for Biochemical Recurrence After Radical Prostatectomy.2018
Author(s)
Takeuchi N, Sakamoto S, Nishiyama A, Horikoshi T, Yamada Y, Iizuka J, Maimaiti M, Imamura Y, Kawamura K, Imamoto T, Komiya A, Ikehara Y, Akakura K, Ichikawa T.
-
Journal Title
Clin Genitourin Cancer
Volume: 「印刷中」
Issue: 4
Pages: e817-e829
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
[Journal Article] Molecular pathogenesis of interstitial cystitis based on microRNA expression signature: miR-320 family-regulated molecular pathways and targets.2018
Author(s)
Arai T, Fuse M, Goto Y, Kaga K, Kurozumi A, Yamada Y, Sugawara S, Okato A, Ichikawa T, Yamanishi T, Seki N.
-
Journal Title
Journal of Human Genetics
Volume: 印刷中
Issue: 5
Pages: 543-554
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Testosterone Reduction of 480 ng/dL Predicts Favorable Prognosis of Japanese Men With Advanced Prostate Cancer Treated With Androgen-Deprivation Therapy.2017
Author(s)
Yamamoto S, Sakamoto S, Minhui X, Tamura T, Otsuka K, Sato K, Maimaiti M, Kamada S, Takei A, Fuse M, Kawamura K, Imamoto T, Komiya A, Akakura K, Ichikawa T.
-
Journal Title
Clin Genitourin Cancer
Volume: 15
Issue: 6
Pages: e1107-e1115
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
-
-
-
-
-
[Journal Article] The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma.2016
Author(s)
Goto Y, Kurozumi A, Nohata N, Kojima S, Matsushita R, Yoshino H, Yamazaki K, Ishida Y, Ichikawa T, Naya Y, Seki N.
-
Journal Title
Oncotarget
Volume: 7
Issue: 37
Pages: 59070-59086
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Presentation] Identification of dual tumor-suppressors (miR-222-5p/miR-222-3p) based on microRNA expression signature by deep sequencing of CRPC.2016
Author(s)
Goto Y, Kojima S, Kurozumi A, Kato M, Okato A, Sakamoto S, Naya Y, Enokida H, Matsushita R, Nakagawa M, Ichikawa T, Seki N.
Organizer
AUA annual meeting 2016
Place of Presentation
San Diego Convention Center, San Diego, 米国 カリフォルニア州
Year and Date
2016-05-06
Related Report
Int'l Joint Research
-